![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves Once-Monthly Osteoporosis Drug
FDA Approves Once-Monthly Osteoporosis Drug
The FDA has approved a once-monthly version of Boniva tablets, an osteoporosis treatment marketed jointly by Roche and GlaxoSmithKline.
The FDA approved a daily version of Boniva (ibandronate sodium) in 2003, but the companies decided not to launch the drug until it developed a more convenient dosing method. Most rival osteoporosis drugs, such as Merck's Fosamax (alendronate sodium) and sanofi-aventis' Actonel (risedronate sodium), must be taken either daily or weekly.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
11Jul
-
18Jul
-
21Oct